Hyaluronic Acid-based Dermal Fillers Market Size, Share & Trends Analysis Report By Application (Wrinkle Removal, Lip Augmentation, Rhinoplasty), By Product; By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global hyaluronic acid-based dermal fillers market size was exhibited at USD 4.85 billion in 2022 and is projected to hit around USD 10.58 billion by 2032, growing at a CAGR of 8.11% during the forecast period 2023 to 2032.

Key Pointers:

• The North America region held the largest market share of 46.9% in 2022 
• Europe is expected to have significant growth during the forecast period. 
• Over the forecast period, the Asia Pacific region is expected to have the fastest growth. 
• Based on the product, the market is segmented into single-phase & duplex products. The single-phase segment had the highest market shares in 2022 of 54.12% and is estimated to have the highest demand during the forecasted period.
• Wrinkle correction dominated the market in 2022 with a share of 28.17%and is estimated to have a significant growth during the forecast period.

Hyaluronic Acid-based Dermal Fillers Market Report Scope

The primary factor driving the growth of the market are the growing demand for non-invasive aesthetic procedures and increasing awareness regarding the application of Hyaluronic Acid (HA) in beauty segment. In addition, increased investment in R&D for novel advanced innovations in dermal products is propelling the market's growth. The trend of aesthetic procedures is growing among men. More men are concerned regarding the negative impact of aging on their appearance & facial features; this is increasing the demand for facial dermal fillers. As per the ISPAS global survey, 12.2% population opting for non-surgical procedures involving HA based fillers, accounted for men.

The advent of technology is shaping the aesthetic market. In 2021, laser resurfacing treatment was introduced in the market having higher efficiency in addressing various skin concerns. The technology applies laser for solving all the dermal issues at once. In addition, the new technology is lower-invasive in response to the demand for non-invasive techniques. Key players are dedicated to the development of advanced solutions to have a competitive edge in the hyaluronic acid market. The increasing number of new product approvals is propelling market opportunities. For instance, in January 2022, RHA Redensity, a novel dermal filler for reducing the wrinkles on skin, received U.S. FDA approval RHA Redensity is a gel implant produced from sodium hyaluronic acid which is injected into particular locations of the facial tissue for smoothening out lines & wrinkles.

The initial phase of the pandemic negatively impacted the market.  The governments & healthcare players had increased focus for supporting the diagnostics & treatment methods for COVID-19.  The disruption in supply of products & equipment for aesthetic procedures & restrictions on the procedures drastically impacted the market. The later part of 2020 witnessed increasing demand for the market. According to the data by the International Society of Plastic Surgery (ISAP in 2020, the overall demand for nonsurgical procedures, hair removal treatment and primarily fillers increased. The demand is expected to be higher post COVID-19 due to rising importance of aesthetic appearance & growing preference for non-invasive procedure.

The stringent government guidelines & regulations in the U.S., Europe Union & international markets for the development, branding & production of HA-based products are restraining the market.  These stringent laws enable that quality products are utilized by healthcare facilities, including doctors as well as other end users. For instance, according to an 2018 FDA report, Juvederm must only be available for sale as well as injected with a licensed healthcare provider's recommendation. The FDA has also recommended patients and their doctors to refrain from using Juvederm Ultra 2, 3, & 4 due to non-approval of the product by U.S. FDA. This is restricting the accessibility of latest products.

Some of the prominent players in the Hyaluronic Acid-based Dermal Fillers Market include:

• Allergan; Galderma Laboratories
• L.P.; Merz Pharmaceuticals
• Genzyme Corporation
• Anika Therapeutics Inc.
• LG Life Sciences,
• LTD (LG Chem)
• Bio plus Co. Ltd.
• Sculpt Luxury
• Dermal Fillers Ltd;
• Bioxis Pharmaceutical;
• Sinclair Pharma; Laboratories
• Vivacy; Bohus Biotech AB

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Hyaluronic Acid-based Dermal Fillers market.

By Product 

• Single Phase Products
• Duplex Products

By Application 

• Wrinkle Correction
• Lip Augmentation
• Rhinoplasty
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)